Cardiac manifestations of subarachnoid hemorrhage

References

• King JT Jr. Epidemiology of aneurysmal subarachnoid hemorrhage. Neuroimaging Clin. N. Am.7, 659–668 (1997).
   PubMed Web of Science ®Google Scholar
• Broderick JP, Brott TG, Duldner JE, Tomsick T, Leach A. Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage. Stroke25, 1342–1347 (1994).
   PubMed Web of Science ®Google Scholar
• Bederson JB, Connolly ES Jr, Batjer HH et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke40, 994–1025 (2009).
   PubMed Web of Science ®Google Scholar
• Claassen J, Vu A, Kreiter KT et al. Effect of acute physiologic derangements on outcome after subarachnoid hemorrhage. Crit. Care Med.32, 832–838 (2004).
   PubMed Web of Science ®Google Scholar
• Urbaniak K, Merchant AI, Amin-Hanjani S, Roitberg B. Cardiac complications after aneurysmal subarachnoid hemorrhage. Surg. Neurol.67, 21–28 (2007).
   PubMedGoogle Scholar
• Davies KR, Gelb AW, Manninen PH, Boughner DR, Bisnaire D. Cardiac function in aneurysmal subarachnoid haemorrhage: a study of electrocardiographic and echocardiographicabnormalities. Br. J. Anaesth.67, 58–63 (1991).
   PubMed Web of Science ®Google Scholar
• Rudehill A, Olsson GL, Sundqvist K, Gordon E. ECG abnormalities in patients with subarachnoid haemorrhage and intracranial tumours. J. Neurol. Neurosurg. Psychiatry50, 1375–1381 (1987).
   PubMed Web of Science ®Google Scholar
• van der Bilt IA, Hasan D, van der top WP et al. Impact of cardiac complications on outcome after aneurysmal subarachnoid hemorrhage: a meta-analysis. Neurology72, 635–642 (2009).
   PubMed Web of Science ®Google Scholar
• Zaroff JG, Pawlikowska L, Miss JC et al. Adrenoceptor polymorphisms and the risk of cardiac injury and dysfunction after subarachnoid hemorrhage. Stroke37, 1680–1685 (2006).
   PubMed Web of Science ®Google Scholar
• Bybee KA, Prasad A. Stress-related cardiomyopathy syndromes. Circulation118, 397–409 (2008).
   PubMed Web of Science ®Google Scholar
• Brouwers PJ, Westenberg HG, Van Gijn J. Noradrenaline concentrations and electrocardiographic abnormalities after aneurysmal subarachnoid haemorrhage. J. Neurol. Neurosurg. Psychiatry58, 614–617 (1995).
   PubMed Web of Science ®Google Scholar
• Masuda T, Sato K, Yamamoto S et al. Sympathetic nervous activity and myocardial damage immediately after subarachnoid hemorrhage in a unique animal model. Stroke33, 1671–1676 (2002).
   PubMed Web of Science ®Google Scholar
• Mayer SA, Lin J, Homm S et al. Myocardial injury and left ventricular performance after subarachnoid hemorrhage. Stroke30, 780–786 (1999).
   PubMed Web of Science ®Google Scholar
• Murphy AM, Kögler H, Marbán E. A mouse model of myocardial stunning. Mol. Med. Today6, 330–331 (2000).
   PubMedGoogle Scholar
• Naidech AM, Kreiter KT, Janjua N et al. Cardiac troponin elevation, cardiovascular morbidity, and outcome after subarachnoid hemorrhage. Circulation112, 2851–2856 (2005).
   PubMed Web of Science ®Google Scholar
• Ramappa P, Thatai D, Coplin W et al. Cardiac troponin-I: a predictor of prognosis in subarachnoid hemorrhage. Neurocrit. Care8, 398–403 (2008).
   PubMed Web of Science ®Google Scholar
• Tung P, Kopelnik A, Banki N et al. Predictors of neurocardiogenic injury after subarachnoid hemorrhage. Stroke35, 548–551 (2004).
   PubMed Web of Science ®Google Scholar
• Schuiling WJ, Dennesen PJ, Tans JT, Kingma LM, Algra A, Rinkel GJ. Troponin I in predicting cardiac or pulmonary complications and outcome in subarachnoid haemorrhage. J. Neurol. Neurosurg. Psychiatry76, 1565–1569 (2005).
   PubMedGoogle Scholar
• Parekh N, Venkatesh B, Cross D et al. Cardiac troponin I predicts myocardial dysfunction in aneurysmal subarachnoid hemorrhage. J. Am. Coll. Cardiol.36, 1328–1335 (2000).
   PubMed Web of Science ®Google Scholar
• Wartenberg KE, Mayer SA. Medical complications after subarachnoid hemorrhage: new strategies for prevention and management. Curr. Opin. Crit. Care12, 78–84 (2006).
   PubMed Web of Science ®Google Scholar
• Bolli R, Marbán E. Molecular and cellular mechanisms of myocardial stunning. Physiol. Rev.79, 609–634 (1999).
   PubMed Web of Science ®Google Scholar
• Banki NM, Kopelnik A, Dae MW et al. Acute neurocardiogenic injury after subarachnoid hemorrhage. Circulation112, 3314–3319 (2005).
   PubMed Web of Science ®Google Scholar
• Kono T, Morita H, Kuroiwa T, Onaka H, Takatsuka H, Fujiwara A. Left ventricular wall motion abnormalities in patients with subarachnoid hemorrhage: neurogenic stunned myocardium. J. Am. Coll. Cardiol.24, 636–40 (1994).
   PubMed Web of Science ®Google Scholar
• Kawai S, Suzuki H, Yamaguchi K, Tanaka K, Sawada H, Aizawa T. ‘Takotsubo’ cardiomyopathy: reversible left ventricular function with ST-segment elevation. Jpn Circ. J.64, 156–159 (2000).
   PubMedGoogle Scholar
• Tsuchihashi K, Ueshima K, Uchida T et al.; Angina Pectoris-Myocardial Infarction Investigations in Japan. Transient left ventricular apical ballooning without coronary artery stenosis: a novel heart syndrome mimicking acute myocardial infarction. J. Am. Coll. Cardiol.38, 11–8 (2001).
   PubMed Web of Science ®Google Scholar
• Gianni M, Dentali F, Grandi AM et al. Apical ballooning syndrome of takotsubo cardiomyopathy: a systematic review. Eur. Heart J.27, 1523–1529 (2006).
   PubMed Web of Science ®Google Scholar
• Merli E, Sutcliffe S, Gori M, Sutherland GG. Tako-tsubo cardiomyopathy: new insights into the possible underlying pathophysiology. Eur. J. Echocardiogr.7, 53–61 (2006).
   PubMed Web of Science ®Google Scholar
• Banki N, Kopelnik A, Tung P et al. Prospective analysis of prevalence, distribution, and rate of recovery of left ventricular systolic dysfunction in patients with subarachnoid hemorrhage. J. Neurosurg.105, 15–20 (2006).
   PubMedGoogle Scholar
• Bolli R, Patel BS, Jeroudi MO, Lai EK, McCay PB. Demonstration of free radical generation in ‘stunned’ myocardium of intact dogs with the use of the spin trap α-phenyl N-tert-butyl nitrone. J. Clin. Invest.82, 476–485 (1988).
   PubMed Web of Science ®Google Scholar
• Lee VH, Connolly HM, Fulgham JR, Manno EM, Brown RD Jr, Wijdicks EF. Tako-tsubo cardiomyopathy in aneurysmal subarachnoid hemorrhage: an underappreciated ventricular dysfunction. J. Neurosurg.105, 264–270 (2006).
   PubMed Web of Science ®Google Scholar
• Przyklenk K. Pharmacologic treatment of the stunned myocardium: the concepts and the challenges. Coron. Artery Dis.12, 363–369 (2001).
   PubMedGoogle Scholar
• Naidech AM, Du Y, Kreiter KT et al. Dobutamine vs. milrinone after subarachnoid hemorrhage. Neurosurgery56, 21–27 (2005).
   PubMedGoogle Scholar
• Apostolides PJ, Greene KA, Zabramski JM, Fitzgerald JW, Spetzler RF. Intra-aortic balloon pump counterpulsation in the management of concomitant cerebral vasospasm and cardiac failure after subarachnoid hemorrhage: technical case report. Neurosurgery38, 1056–1060 (1996).
   PubMed Web of Science ®Google Scholar
• Taccone FS, Lubicz B, Piagnerelli M, van Nuffelen M, Vincent JL, De Backer D. Cardiogenic shock with stunned myocardium during triple-H therapy treated with intra-aortic balloon pump counterpulsation. Neurocrit. Care10, 76–82 (2009).
   PubMedGoogle Scholar
• Brouwers PJ, Wijdicks EF, Hasan D et al. Serial electrocardiographic recording in aneurysmal subarachnoid hemorrhage. Stroke20, 1162–1167 (1989).
   PubMed Web of Science ®Google Scholar
• Sommargren CE, Zaroff JG, Banki N, Drew BJ. Electrocardiographic repolarization abnormalities in subarachnoid hemorrhage. J. Electrocardiol.35(Suppl.), 257–262 (2002).
   PubMedGoogle Scholar
• Sommargren CE. Electrocardiographic abnormalities in patients with subarachnoid hemorrhage. Am. J. Crit. Care11, 48–56 (2002).
   PubMed Web of Science ®Google Scholar
• Zaroff JG, Rordorf GA, Newell JB, Ogilvy CS, Levinson JR. Cardiac outcome in patients with subarachnoid hemorrhage and electrocardiographic abnormalities. Neurosurgery44, 34–40 (1999).
   PubMed Web of Science ®Google Scholar
• van den Bergh WM, Algra A, Rinkel GJ. Electrocardiographic abnormalities and serum magnesium in patients with subarachnoid hemorrhage. Stroke35, 644–648 (2004).
   PubMed Web of Science ®Google Scholar
• Sakr YS, Lim N, Amaral AC et al. Relation of ECG changes toneurological outcome in patients with aneurysmal subarachnoid hemorrhage. Int. J. Card.96, 369–373 (2004).
   PubMed Web of Science ®Google Scholar
• Jung JH, Min PK, Rim SJ, Ha JW, Chung N, Lee KC. Are electrocardiographic changes in patients with acute subarachnoid hemorrhage associated with Takotsubo cardiomyopathy? Cardiology115, 98–106 (2010).
   PubMed Web of Science ®Google Scholar
• Andreoli A, di Pasquale G, Pinelli G, Grazi P, Tognetti F, Testa C. Subarachnoid hemorrhage: frequency and severity of cardiac arrhythmias. A survey of 70 cases studied in the acute phase. Stroke18, 558–564 (1987).
   PubMed Web of Science ®Google Scholar
• Frontera JA, Parra A, Shimbo D et al. Cardiac arrhythmias after subarachnoid hemorrhage: risk factors and impact on outcome. Cerebrovasc. Dis.26, 71–78 (2008).
   PubMed Web of Science ®Google Scholar
• Frangiskakis JM, Hravnak M, Crago EA et al. Ventricular arrhythmia risk after subarachnoid hemorrhage. Neurocrit. Care10, 287–294 (2009).
   PubMedGoogle Scholar
• Stober T, Anstatt T, Sen S, Schimrigk K, Jager H. Cardiac arrhythmias in subarachnoid haemorrhage. Acta Neurochir.93, 37–44 (1988).
   PubMed Web of Science ®Google Scholar
• Kürkciyan I, Meron G, Sterz F et al. Spontaneous subarachnoid haemorrhage as a cause of out-of-hospital cardiac arrest. Resuscitation51, 27–32 (2001).
   PubMedGoogle Scholar